Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Thomas

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Social Science & Medicine (1982)|June 30, 2015
Closing the health and nutrition gap in Odisha, India: A case study of how transforming the health system is achieving greater equityDeborah Thomas, Biraj Laxmi Sarangi, Anu Garg, et al.
Cancer|March 11, 2003
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromesApostolia Tsimberidou, Elihu Estey, Jorge Cortes, et al.
Blood|September 1, 2005
A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine)Varsha Gandhi, John M Kilpatrick, William Plunkett, et al.
Cancer|May 27, 2003
Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disordersJorge Cortes, Francis Giles, Susan O'Brien, et al.
American Journal of Clinical Pathology|October 12, 2002
Differences in CD33 intensity between various myeloid neoplasmsIman Jilani, Elihu Estey, Yang Huh, et al.
Psychology of Sport and Exercise|April 5, 2012
Building a multiple modality, theory-based physical activity intervention: The development of CardiACTION!Paul A Estabrooks, Russ E Glasgow, Stan Xu, et al.
Blood|November 26, 2002
Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significanceTaghi Manshouri, Kim-anh Do, Xuemei Wang, et al.
British Journal of Haematology|June 29, 2006
Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapseFrancis Giles, Srdan Verstovsek, Guillermo Garcia-Manero, et al.
Pediatrics|May 20, 2025
Adultification of Young Black Females on Their Health and Well-being: A Qualitative StudyDaniela Brissett, Tawanna Jones, Merrian Brooks, et al.
Blood|March 15, 2003
Result of high-dose imatinib mesylate in patients with Philadelphia chromosome-positive chronic myeloid leukemia after failure of interferon-alphaJorge Cortes, Francis Giles, Susan O'Brien, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Social Science & Medicine (1982)|June 30, 2015
Closing the health and nutrition gap in Odisha, India: A case study of how transforming the health system is achieving greater equityDeborah Thomas, Biraj Laxmi Sarangi, Anu Garg, et al.
Cancer|March 11, 2003
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromesApostolia Tsimberidou, Elihu Estey, Jorge Cortes, et al.
Blood|September 1, 2005
A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine)Varsha Gandhi, John M Kilpatrick, William Plunkett, et al.
Cancer|May 27, 2003
Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disordersJorge Cortes, Francis Giles, Susan O'Brien, et al.
American Journal of Clinical Pathology|October 12, 2002
Differences in CD33 intensity between various myeloid neoplasmsIman Jilani, Elihu Estey, Yang Huh, et al.
Psychology of Sport and Exercise|April 5, 2012
Building a multiple modality, theory-based physical activity intervention: The development of CardiACTION!Paul A Estabrooks, Russ E Glasgow, Stan Xu, et al.
Blood|November 26, 2002
Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significanceTaghi Manshouri, Kim-anh Do, Xuemei Wang, et al.
British Journal of Haematology|June 29, 2006
Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapseFrancis Giles, Srdan Verstovsek, Guillermo Garcia-Manero, et al.
Pediatrics|May 20, 2025
Adultification of Young Black Females on Their Health and Well-being: A Qualitative StudyDaniela Brissett, Tawanna Jones, Merrian Brooks, et al.
Blood|March 15, 2003
Result of high-dose imatinib mesylate in patients with Philadelphia chromosome-positive chronic myeloid leukemia after failure of interferon-alphaJorge Cortes, Francis Giles, Susan O'Brien, et al.
Pageof 16